Alliance Pharma plc (AIM: APH)
London
· Delayed Price · Currency is GBP · Price in GBX44.85
+0.55 (1.24%)
Nov 21, 2024, 8:58 AM GMT+1
Alliance Pharma Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 239 | 219 | 286 | 585 | 467 | 444 | Upgrade
|
| Market Cap Growth | -21.93% | -23.53% | -51.11% | 25.47% | 5.06% | 27.94% | Upgrade
|
| Enterprise Value | 326 | 317 | 393 | 694 | 522 | 522 | Upgrade
|
| Last Close Price | 0.44 | 0.41 | 0.52 | 1.04 | 0.83 | 0.79 | Upgrade
|
| PE Ratio | - | - | - | 77.19 | 55.40 | 16.67 | Upgrade
|
| Forward PE | 9.49 | 8.13 | 9.41 | 17.58 | 16.56 | 16.20 | Upgrade
|
| PS Ratio | 1.31 | 1.21 | 1.71 | 3.59 | 3.59 | 3.27 | Upgrade
|
| PB Ratio | 1.07 | 1.00 | 1.08 | 2.07 | 1.66 | 1.62 | Upgrade
|
| P/FCF Ratio | 8.25 | 7.13 | 13.88 | 15.76 | 12.63 | 14.05 | Upgrade
|
| P/OCF Ratio | 6.95 | 6.97 | 13.65 | 15.14 | 11.22 | 12.42 | Upgrade
|
| PEG Ratio | 1.68 | 1.20 | 0.94 | 1.85 | 1.53 | 1.53 | Upgrade
|
| EV/Sales Ratio | 1.78 | 1.76 | 2.35 | 4.26 | 4.02 | 3.85 | Upgrade
|
| EV/EBITDA Ratio | 6.24 | 6.32 | 10.80 | 15.00 | 13.81 | 13.50 | Upgrade
|
| EV/EBIT Ratio | 7.47 | 7.46 | 13.82 | 18.05 | 17.58 | 13.83 | Upgrade
|
| EV/FCF Ratio | 11.23 | 10.33 | 19.07 | 18.70 | 14.12 | 16.51 | Upgrade
|
| Debt / Equity Ratio | 0.47 | 0.54 | 0.52 | 0.42 | 0.51 | 0.29 | Upgrade
|
| Debt / EBITDA Ratio | 2.02 | 2.30 | 3.70 | 2.52 | 3.68 | 2.03 | Upgrade
|
| Debt / FCF Ratio | 3.64 | 3.82 | 6.67 | 3.20 | 3.84 | 2.53 | Upgrade
|
| Asset Turnover | 0.40 | 0.39 | 0.33 | 0.32 | 0.28 | 0.33 | Upgrade
|
| Inventory Turnover | 2.72 | 3.03 | 2.90 | 2.44 | 2.44 | 2.90 | Upgrade
|
| Quick Ratio | 1.97 | 1.83 | 1.70 | 1.40 | 1.76 | 1.99 | Upgrade
|
| Current Ratio | 2.93 | 2.57 | 2.24 | 2.00 | 2.56 | 2.69 | Upgrade
|
| Return on Equity (ROE) | -13.44% | -13.71% | -7.74% | 2.60% | 2.89% | 9.50% | Upgrade
|
| Return on Assets (ROA) | 5.98% | 5.76% | 3.51% | 4.75% | 4.05% | 5.81% | Upgrade
|
| Return on Capital (ROIC) | 7.47% | 7.21% | 4.42% | 5.83% | 4.77% | 6.68% | Upgrade
|
| Earnings Yield | -15.98% | -15.14% | -7.41% | 1.25% | 1.72% | 5.63% | Upgrade
|
| FCF Yield | 13.81% | 14.03% | 7.20% | 6.34% | 7.92% | 7.12% | Upgrade
|
| Dividend Yield | 0.00% | - | 3.43% | 1.62% | 1.95% | 0.68% | Upgrade
|
| Payout Ratio | 0.00% | - | - | 117.56% | 35.34% | 30.37% | Upgrade
|
| Buyback Yield / Dilution | -0.07% | -0.12% | 0.53% | -0.93% | -1.35% | -3.87% | Upgrade
|
| Total Shareholder Return | -0.07% | -0.12% | 3.95% | 0.69% | 0.60% | -3.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.